FAYE M JOHNSON's research topics

FAYE M JOHNSON

Concepts (464)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with FAYE M JOHNSON's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that FAYE M JOHNSON has written about over time.

Thiazoles, 10 publications between 2005 and 2012, average publication date October 2009. Pyrimidines, 19 publications between 2004 and 2017, average publication date April 2010. ErbB Receptors, 17 publications between 2004 and 2018, average publication date December 2010. src-Family Kinases, 16 publications between 2005 and 2017, average publication date January 2011. Dasatinib, 13 publications between 2005 and 2017, average publication date March 2011. Lung Neoplasms, 33 publications between 2003 and 2021, average publication date February 2012. Carcinoma, Non-Small-Cell Lung, 18 publications between 2005 and 2019, average publication date October 2012. Erlotinib Hydrochloride, 6 publications between 2008 and 2018, average publication date February 2013. Antineoplastic Agents, 28 publications between 2004 and 2023, average publication date July 2013. Apoptosis, 23 publications between 2005 and 2022, average publication date June 2014. Protein Kinase Inhibitors, 28 publications between 2007 and 2021, average publication date August 2014. Carcinoma, Squamous Cell, 31 publications between 2004 and 2021, average publication date October 2014. Head and Neck Neoplasms, 29 publications between 2004 and 2023, average publication date May 2015. Proto-Oncogene Proteins, 5 publications between 2010 and 2019, average publication date November 2015. Pteridines, 5 publications between 2015 and 2019, average publication date June 2017. Cell Cycle Proteins, 8 publications between 2015 and 2022, average publication date September 2017. Papillomavirus Infections, 9 publications between 2015 and 2022, average publication date September 2018. Receptor, Notch1, 4 publications between 2019 and 2022, average publication date June 2021.

Thiazoles
Pyrimidines
ErbB Receptors
src-Family Kinases
Dasatinib
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Erlotinib Hydrochloride
Antineoplastic Agents
Apoptosis
Protein Kinase Inhibitors
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Proto-Oncogene Proteins
Pteridines
Cell Cycle Proteins
Papillomavirus Infections
Receptor, Notch1

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Thiazoles	10	2005	2012	October 2009
Pyrimidines	19	2004	2017	April 2010
ErbB Receptors	17	2004	2018	December 2010
src-Family Kinases	16	2005	2017	January 2011
Dasatinib	13	2005	2017	March 2011
Lung Neoplasms	33	2003	2021	February 2012
Carcinoma, Non-Small-Cell Lung	18	2005	2019	October 2012
Erlotinib Hydrochloride	6	2008	2018	February 2013
Antineoplastic Agents	28	2004	2023	July 2013
Apoptosis	23	2005	2022	June 2014
Protein Kinase Inhibitors	28	2007	2021	August 2014
Carcinoma, Squamous Cell	31	2004	2021	October 2014
Head and Neck Neoplasms	29	2004	2023	May 2015
Proto-Oncogene Proteins	5	2010	2019	November 2015
Pteridines	5	2015	2019	June 2017
Cell Cycle Proteins	8	2015	2022	September 2017
Papillomavirus Infections	9	2015	2022	September 2018
Receptor, Notch1	4	2019	2022	June 2021

JOHNSON's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (464)

Explore

Co-Authors (138)

Explore

Similar People (60)

Explore

Same Department

Explore